focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 9.80
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 13th Aug 2019 15:58

Wednesday 14 August 
AvastHalf Year Results
LookersHalf Year Results
Balfour BeattyHalf Year Results
Admiral GroupHalf Year Results
PrudentialHalf Year Results (at 0930 BST)
Apax Global AlphaHalf Year Results
CLS HoldingsHalf Year Results
Hochschild MiningHalf Year Results
Georgia Healthcare GroupHalf Year Results
Bank of GeorgiaHalf Year Results
Riverstone EnergyHalf Year Results
JPMorgan American Investment TrustHalf Year Results
Thursday 15 August 
TBC BankHalf Year Results
GVC HoldingsHalf Year Results
MarshallsHalf Year Results
KAZ MineralsHalf Year Results
Gem DiamondsTrading Statement
Friday 16 August 
no events scheduled 
Monday 19 August 
BATM Advanced CommunicationsHalf Year Results
Tuesday 20 August 
BHP GroupFull Year Results
John Wood GroupHalf Year Results
FinablrHalf Year Results
PersimmonHalf Year Results
Scancell HoldingsHalf Year Results
Tribal GroupHalf Year Results
Empiric Student PropertyHalf Year Results
HostelworldHalf Year Results
Global Ports HoldingsHalf Year Results
Kenmare ResourcesHalf Year Results
  

More News
18 Sep 2015 09:23

Bigger loss but positive drug trial results for Scancell Holdings

(ShareCast News) - Scancell Holdings's losses increased marginally in the year ended 30 April 2015. The cancer immunotherapy developer announced on Friday a wider loss of £2.414m from £2.222m last year. It comes as a result of expected additional expenditure on its SCIB1 ImmunoBody clinical trials

Read more
18 Sep 2015 07:49

Scancell Holdings Loss Wider On Higher Development Costs

Read more
30 Jul 2015 09:40

Scancell Signs Research Collaboration Deal With ImmunID

Read more
9 Jul 2015 08:57

Scancell Closes Patient Recruitment For Next Phase Of SCIB1 Trials

Read more
2 Jun 2015 12:19

Scancell gives positive update on melanoma treatment data

Biopharmaceutical company Scancell Holdings reported further encouraging results from the ongoing 'Phase 1/2' clinical trial of its melanoma treatment SCIB1, which it presented at the annual meeting of the American Society of Clinical Oncology in Chicago. The data showed that all 16 patients with re

Read more
2 Jun 2015 07:27

Scancell Reports Encouraging Ongoing SCIB1Trial Results

Read more
24 Mar 2015 10:21

Scancell Says New Data Supports SCIB2 Combination Treatment

Read more
12 Jan 2015 09:47

Scancell Sees Positive Data In On-Going Phase I/2 SCIB1Trial

Read more
14 Oct 2014 11:23

UK MIDDAY BRIEFING: Life's No Catwalk For Luxury Goods Makers

Read more
14 Oct 2014 11:09

UK WINNERS & LOSERS: Miners Continue Run, Oil Companies Fall

Read more
14 Oct 2014 07:44

Scancell Shares Boosted By Positive SCIB-1 Trial Results

Read more
14 Oct 2014 07:32

UK MORNING BRIEFING: Burberry And Hargreaves Lansdown Lead Declines

Read more
14 Oct 2014 05:22

UK AGM, EGM Calendar - Week Ahead

Read more
13 Oct 2014 14:57

UK AGM, EGM Calendar - Week Ahead

Read more
13 Oct 2014 05:30

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.